A detailed history of Tower Research Capital LLC (Trc) transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 10,160 shares of FHTX stock, worth $81,991. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,160
Previous 394 2478.68%
Holding current value
$81,991
Previous $2,000 2800.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.05 - $8.0 $49,318 - $78,128
9,766 Added 2478.68%
10,160 $58,000
Q1 2024

May 15, 2024

SELL
$2.82 - $7.94 $3,195 - $8,996
-1,133 Reduced 74.2%
394 $2,000
Q4 2023

Feb 13, 2024

SELL
$2.94 - $6.76 $9,978 - $22,943
-3,394 Reduced 68.97%
1,527 $9,000
Q3 2023

Nov 14, 2023

BUY
$5.0 - $9.87 $18,460 - $36,440
3,692 Added 300.41%
4,921 $24,000
Q2 2023

Aug 14, 2023

SELL
$5.37 - $8.84 $6,094 - $10,033
-1,135 Reduced 48.01%
1,229 $8,000
Q1 2023

May 09, 2023

BUY
$4.66 - $8.99 $5,181 - $9,996
1,112 Added 88.82%
2,364 $15,000
Q4 2022

Feb 10, 2023

SELL
$5.44 - $9.46 $13,246 - $23,035
-2,435 Reduced 66.04%
1,252 $8,000
Q3 2022

Nov 10, 2022

BUY
$7.52 - $18.01 $13,287 - $31,823
1,767 Added 92.03%
3,687 $31,000
Q2 2022

Aug 15, 2022

BUY
$8.48 - $16.84 $8,700 - $17,277
1,026 Added 114.77%
1,920 $26,000
Q1 2022

May 12, 2022

SELL
$8.87 - $22.1 $7,450 - $18,564
-840 Reduced 48.44%
894 $14,000
Q4 2021

Feb 14, 2022

BUY
$10.79 - $22.87 $9,851 - $20,880
913 Added 111.21%
1,734 $39,000
Q3 2021

Nov 15, 2021

SELL
$8.33 - $15.02 $4,814 - $8,681
-578 Reduced 41.32%
821 $11,000
Q2 2021

Aug 16, 2021

SELL
$9.32 - $13.26 $5,293 - $7,531
-568 Reduced 28.88%
1,399 $15,000
Q1 2021

May 17, 2021

BUY
$11.8 - $23.11 $18,042 - $35,335
1,529 Added 349.09%
1,967 $26,000
Q4 2020

Feb 16, 2021

BUY
$15.12 - $25.88 $6,622 - $11,335
438 New
438 $9,000

Others Institutions Holding FHTX

About Foghorn Therapeutics Inc.


  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $336M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.